Reported Nov 23, 2022 · Terminated
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
ImprimisRx NJ
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: ImprimisRx NJ · 1705 Us Highway 46 Ste 4 · Ledgewood, NJ · 07852-9720
Is this the product you have?
- Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
- Lot codes and dates
Lot # 06272022@3Exp. date 11/24/2022 Lot # 08302022@1Exp. date 01/27/2023
- Amount recalled
- 960 bottles
Where it was sold
- Nationwide
Why it was recalled
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new ImprimisRx NJ recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.